Filing Details
- Accession Number:
- 0001415889-21-003257
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-29 17:25:55
- Reporting Period:
- 2021-06-28
- Accepted Time:
- 2021-06-29 17:25:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1479419 | Kala Pharmaceuticals Inc. | KALA | Pharmaceutical Preparations (2834) | 270604595 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1605767 | Todd Bazemore | C/O Kala Pharmaceuticals, Inc. 490 Arsenal Way, Suite 120 Watertown MA 02472 | Chief Operating Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-06-28 | 2,911 | $5.77 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 42 | Indirect | By son |
Footnotes
- This sale was made pursuant to a 10b5-1 trading plan to cover tax withholding obligations in connection with the vesting and settlement of the reporting person's restricted stock units granted on June 25, 2020.
- Includes 118,000 unvested RSUs.
- The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Billionaire Hedge Funds
